Prevalence rate of hypertension in men aged 30-79 in North Korea
North Korea: Prevalence rate of hypertension in men aged 30-79 was 28.1 in 2019. ▲ Rising
Prevalence rate of hypertension in men aged 30-79 in North Korea, 1990–2019
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
The most recent figure for prevalence rate of hypertension in men aged 30-79 in North Korea is 28.1, measured in 2019.
The figure is down 1.7% over ten years.
Over the whole period, prevalence rate of hypertension in men aged 30-79 in North Korea peaked at 28.6 in 2008 and was at its lowest, 25.9, in 1990.
North Korea ranks 183rd of 195 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 30 years of available data.
Prevalence rate of hypertension in men aged 30-79 in North Korea, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 25.9 | — |
| 1991 | 26.2 | +1.2% |
| 1992 | 26.5 | +1.1% |
| 1993 | 26.8 | +1.1% |
| 1994 | 27.1 | +1.1% |
| 1995 | 27.3 | +0.7% |
| 1996 | 27.4 | +0.4% |
| 1997 | 27.6 | +0.7% |
| 1998 | 27.7 | +0.4% |
| 1999 | 27.8 | +0.4% |
| 2000 | 27.9 | +0.4% |
| 2001 | 28 | +0.4% |
| 2002 | 28.1 | +0.4% |
| 2003 | 28.2 | +0.4% |
| 2004 | 28.3 | +0.4% |
| 2005 | 28.4 | +0.4% |
| 2006 | 28.4 | +0.0% |
| 2007 | 28.5 | +0.4% |
| 2008 | 28.6 | +0.4% |
| 2009 | 28.6 | +0.0% |
| 2010 | 28.6 | +0.0% |
| 2011 | 28.5 | -0.3% |
| 2012 | 28.4 | -0.4% |
| 2013 | 28.4 | +0.0% |
| 2014 | 28.3 | -0.4% |
| 2015 | 28.2 | -0.4% |
| 2016 | 28.2 | +0.0% |
| 2017 | 28.1 | -0.4% |
| 2018 | 28.1 | +0.0% |
| 2019 | 28.1 | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 27.03 | 25.9 | 27.8 | 10 |
| 2000s | 28.3 | 27.9 | 28.6 | 10 |
| 2010s | 28.29 | 28.1 | 28.6 | 10 |
Countries ranked near North Korea
More gender data for North Korea
- Child population (UN estimates and projections) 4,948 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.7158 % change on previous year (2030)
- Age population, age 00, female, interpolated 162,142 (2025)
- Age population, age 00, male, interpolated 171,689 (2025)
- Age population, age 01, female, interpolated 163,466 (2025)
- Age population, age 01, male, interpolated 172,928 (2025)
- Age population, age 02, female, interpolated 164,613 (2025)
- Age population, age 02, male, interpolated 173,969 (2025)
- Age population, age 03, female, interpolated 165,947 (2025)
- Age population, age 03, male, interpolated 175,324 (2025)
Frequently asked questions
- What is prevalence rate of hypertension in men aged 30-79 in North Korea?
- Prevalence rate of hypertension in men aged 30-79 in North Korea was 28.1 in 2019, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest prevalence rate of hypertension in men aged 30-79 recorded in North Korea?
- The highest recorded value was 28.6 in 2008.
- What is the lowest prevalence rate of hypertension in men aged 30-79 recorded in North Korea?
- The lowest recorded value was 25.9 in 1990.
- How does North Korea rank for prevalence rate of hypertension in men aged 30-79?
- North Korea ranks 183rd out of 195 countries with data for 2019.
- Is prevalence rate of hypertension in men aged 30-79 rising or falling in North Korea?
- Over the last ten years it is down 1.7%. The long-run trend across the full record is rising.
- Where does this North Korea data come from?
- The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Prevalence rate of hypertension in men aged 30-79. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.